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Proteinuria in IgA nephropathy
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Proteinuria in IgA nephropathy. Clinicopathological data in 74 pa-
tients with IgA nephropathy were analyzed with special attention to
level of proteinuria and its prognostic significance in this disease.
Excretion rates exceeding 3 g per day (heavy), in the range of I to 2.9
g (moderate) and under I g per day (mild) each occurred in approxi-
mately equal proportions of patients. One-sixth of those with more than
I g developed end-stage renal failure, while serum creatinine never
exceeded 2 mg/dl in any with mild proteinuria. "Renal survival" (serum
creatinine of 2 mg/dl or less) at five years after presentation was 100%
in patients with persistently mild proteinuria, 87% in those whose
protein excretion reached the moderate range, and 69% when heavy or
nephrotic range proteinuria developed. Of significance, only rarely did
mild proteinuria at presentation increase to higher levels. A correlation
existed between level of protein excretion and severity of mesangial,
segmental or global proliferation, glomerulosclerosis, podocyte efface-
ment, interstitial infiltration, tubular atrophy and vascular sclerosis,
even in patients with unimpaired renal function. Moderate or heavy
proteinuria typically preceded the onset of hypertension and occurred
prior to the development of renal insufficiency. Our results underscore
magnitude of proteinuria as an early marker of glomerular damage in the
prognosis of IgA nephropathy.
Since the first description of mesangial IgA nephropathy [1],
the disease has been observed world wide. The primary form of
IgA nephropathy (Berger's disease) is defined immunopatho-
logically by predominant mesangial deposition of IgA, accom-
panied by C3 or other immunoglobulins. The spectrum of
histological abnormalities includes a full range of glomerular
changes from normal or minimal to various combinations of
proliferation in the mesangium and peripheral capillary loops,
tuft necrosis and small or circumferential crescents. Clinically
IgA nephropathy is a chronic disease characterized by micro-
hematuria with or without episodes of gross hematuria, often
with minimal proteinuria.
IgA nephropathy was originally considered a benign disease
with favorable prognosis [1]. Subsequently, its frequently pro-
gressive nature has been noted [2—71,and it has been estimated
that this form of glomerular disease may account for as much as
10% of all end-stage renal failure cases [8]. As with other
intrinsic renal diseases, once hypertension and renal functional
impairment develop, eventual progression to uremia is inevita-
ble. Similarly, the histological findings of glomerular sclerosis,
vascular sclerosis and interstitial fibrosis carry the anticipated
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poor prognosis associated with irreversible parenchymal dam-
age [9—131. Obviously it would be helpful to identify early
clinical or histological features which bear prognostic signifi-
cance.
In the present study we have examined the correlations
between extent of proteinuria and the clinical course of IgA
nephropathy. The findings clearly demonstrate a benign out-
come with minimal proteinuria and an unfavorable prognosis
with moderate or heavy proteinuria.
Methods
Clinical and pathological data of all patients with the diagno-
sis of IgA nephropathy at NYU Medical Center from July 1970
through December 1983 were reviewed. The diagnosis was
made if immunofluorescence revealed the predominance of
immunoglobulin A deposits in glomeruli in the absence of lupus
erythematosus, cirrhosis of the liver and Henoch-Schonlein
purpura. Out of 78 patients who satisfied these criteria, 74 with
sufficient data on their level of proteinuria form the basis of this
study. Proteinuria was said to be mild if 24-hour urine protein
excretion was less than I g, moderate if it was between 1 and 2.9
g and heavy if in the nephrotic range, that is, 3 g or more.
Twenty-four-hour urinary protein determinations were per-
formed as clinically indicated. All except six patients with mild
proteinuria had one or more quantitative determination. These
six had multiple qualitative urinalyses showing negative to trace
amounts of protein excretion. Three or more quantitative
determinations, ranging up to 35 per patient, were available in
24% of those with mild proteinuria, 45% with moderate protein-
uria and 60% with heavy proteinuria. Greater than 2 red cells
per high power field was interpreted as microscopic hematuria.
Hypertension was defined as a systolic blood pressure of 160
mm Hg or greater, or a diastolic exceeding 90 mm Hg.
Renal biopsies were fixed in Zenkers FU48, cut at 2 to 3
microns and stained with hematoxylin eosin, periodic acid
silvermethenamine counterstained with hematoxylin and eosin,
and in some cases with periodic acid Schiff and azacarmine.
Tissue for immunofluorescence was frozen in a cryostat, sec-
tioned at 4 microns and reacted with fluorescein-labelled anti-
sera against IgG, IgA, 1gM (heavy chain specific), C3 and
fibrinogen-fibrin. Some biopsies were also stained with fluores-
cein-labelled antisera each monospecific against kappa or
lambda light chain, C4 and Clq. For electron microscopy,
material was fixed in 2.5% buffered gluteraldehyde, post-fixed
in osmium tetroxide and embedded in epon. Thin sections
double-stained with uranyl acetate and lead citrate were exam-
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Fig. 1. Sex and age at presentation of IgA nephropathy. Males pre-
dominate. Peak age for presentation is third decade. Symbols are: (LI)
male; () female.
med and photographed in a Zeiss EM9 or EM1OA electron
microscope.
Biopsies that contained at least 7 glomeruli were included for
analysis. Chi-square contingency table analysis was used to test
the frequency distribution of single clinical and im-
munopathologic features in the three groups representing in-
creasing levels of proteinuria. In each biopsy the severity of
mesangial proliferation, interstitial infiltration and tubular atro-
phy was semiquantitatively graded from 0 to 2+, and vascular
sclerosis from 0 to 3+. Electron microscopic findings of in-
crease in mesangial matrix and podocyte effacement were
graded 0 to 2+ and mesangial deposits 0 to 3+. The median
ranks of the three groups with increasing levels of proteinuria
were compared using Wilcoxon test between two groups and
Kruskal-Wallis test for ordered classification among three
groups.
Life table analysis of patients according to gender, age
distribution and different levels of proteinuria was performed by
the method of Cutler and Ederer [14] and compared using the
log rank test. A P value of less than 0.05 was considered
significant. For life table analysis, we selected as end-point a
serum creatinine concentration exceeding 2 mg/dl, as indicative
of unequivocal impairment of renal function. In a slowly
progressive disease such as IgA nephropathy, the use of end-
stage renal failure as end-point makes identification of a prog-
nostic feature much more difficult and would over-estimate the
number with a favorable prognosis.
Results
Mode of presentation
Presentation was most common in the second and third
decades (51% of all cases; Fig. 1). Forty-seven patients were
male and 27 female. Thirty-six were caucasian, 23 hispanic, 8
oriental, 4 black and 3 of other ethnic groups. Rarity of this
disease in blacks has been observed by others [15, 16]. Blacks
accounted for 5.4% of patients with IgA nephropathy in our
series whereas the proportion of blacks treated in our medical
center is 37.5%. Thirty-four patients (46%) presented with gross
hematuria, 34 with an abnormal urinalysis on routine examina-
tion, 5 with edema and I with uremia.
An "acute nephritic" onset, defined as fluid retention with
transient hypertension, occurred in 5 patients, 3 of whom had
gross hematuria, 4 edema and 2 circulatory congestion. Hyper-
tension subsided within 2 months in all 5 patients, and renal
function remained normal on subsequent follow-up.
Gross hematuria
In addition to 34 patients who presented with gross
hematuria, 6 others developed it subsequently, a total of 40 in
all. Gross hematuria occurred repeatedly in 31. In 23 of the 40
patients it was associated with an upper respiratory illness, or in
some cases abdominal symptoms.
Microscopic hematuria
Microscopic hematuria was commonly present between epi-
sodes of gross hematuria. Of the 34 patients without gross
hematuria, microscopic hematuria was observed in all but 3.
Protein uria
Proteinuria was present in all but four patients, but in only
one of these four was its absence documented on more than one
occasion. Maximum level of 24-hour protein excretion during
the period of observation reached 3 g or more in 25 (Group III),
1 to 2.9 g in 20 (Group II) and was less than 1 g in 29 patients
(Group I). Of the 25 patients in Group III, 13 demonstrated
heavy proteinuria at the time of presentation and 12 developed
it 6 months to 10 years later. Among these 12, proteinuria had
been in the moderate range (1.0 to 2.9 g) in five individuals and
in the mild range (less than I g) in two prior to becoming heavy.
Such information was not available in the remaining five pa-
tients. Of the 13 with early heavy proteinuria, it declined in five
after three months to a year; three of these five had an "acute
nephritic" presentation. Heavy proteinuria proved to be per-
sistent in the remaining eight who demonstrated this feature at
presentation, and in all 12 who developed it later. As will be
seen, persistent heavy proteinuria was associated with a poor
prognosis.
Hypertension
Hypertension was observed in a total of 27 patients (36.5%).
Eighteen were hypertensive on presentation; in five of these,
hypertension was considered an "acute nephritic" manifesta-
tion since it proved to be transient (see above). Of the 22
patients with persistent hypertension, 14 had a serum creatinine
concentration of less than 2 mg/dl at onset of hypertension. Ten
of these 14 were available for follow up; in five, renal function
remained stable over a period of I to 8-1/2 years, while in the
others it deteriorated over 1 to 10 years to end-stage renal
disease in three (all with heavy proteinuria), and in two to
serum creatinine concentrations of 2 and 2.1 mg/dl. Eight of the
22 patients with persistent hypertension had serum creatinines
ranging from 2 to 5.8 mg/dl when hypertension was first
detected. Follow up was available in seven of these; three
reached end-stage renal failure and three showed deterioration
of renal function with creatinine concentrations of 4.4, 7.5, and
8.5 mg/dl at latest observation. The other patient had a stable
creatinine of 2 mg/dl over a two year period. In 13 of 22 patients
(59%) with persistent hypertension serum creatinine concentra-
tions of 2 mg/dl or greater developed, while 15 of 21 (71%) with
serum creatinines of 2 mgldl or more were hypertensive,
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30% and 36% in Groups II and Ill (NS). Patients with recurrent
gross hematuria (51 .6%) had mild proteinuria compared to 35%
in the others. Persistent hypertension developed in 48% of
Group III, 40% of Group II and 7% of Group I (P for Group! vs.
Group II <0.05, Group I vs. Group II! <0.01 and Group II vs.
Group III NS). Moderate to heavy proteinuria preceded devel-
opment of hypertension in the vast majority of patients. Twenty
of 22 patients with persistent hypertension (90%) already had
moderate to heavy proteinuria at the time of discovery of
hypertension. Significantly, 24 of 34 patients (70%) with mod-
erate and heavy proteinuria at presentation were not yet hyper-
tensive. Seven out of 12 patients with heavy proteinuria and
persistent hypertension developed either end stage renal failure
or advanced renal insufficiency.
Proteinuria and development of rena/functional impairment.
The latest serum creatinine concentrations in patients who
developed the different levels of maximal proteinuria are shown
in Figure 2. Forty per cent of Group III and 25% of Group II
developed serum creatinines exceeding 2 mg/dl at the end of a
mean follow-up period of 34 months and 61 months, respec-
tively, whereas no patient in Group I reached a serum creati-
nine exceeding 2 mg/dl after a mean follow-up of 84 months.
Five in Group I! and eight in Group III reached serum creati-
nines exceeding 3 mg/dl; two in the former and five in the latter
progressed to end-stage renal failure.
Utilizing a serum creatinine concentration in excess of 2
mg/dl as the end point, life table analysis was performed
according to the method of Cutler and Ederer [14]. Figure 3
shows "renal survival" according to maximal level of protein-
uria which was attained during their course in 67 patients with
serum creatinine of 2 mg/dl or less at presentation. Group III
patients were more likely to experience renal functional impair-
ment than those in Group I (P < 0.001), "Renal survival" in
Group II was intermediate between these two extremes. "Renal
survival" at five years after presentation of renal disease was
100% in Group I, 87% in Group II and 69% in Group III. Five
years from the first appearance of heavy proteinuria "renal
survival" proved to be only 55%.
The prognostic significance of level of proteinuria at presen-
tation of IgA nephropathy is plotted in Figure 4. Thirty-three
patients with mild proteinuria, 18 with moderate proteinuria and
13 with heavy proteinuria at presentation who had serum
creatinine of 2 mg/dl or less were the subjects of this analysis.
Again, a serum creatinine concentration exceeding 2 mg/dl was
taken as the end point for "renal survival". Using a log rank
test for trend as described by Peto et al [17], the relative risk of
ultimate renal functional impairment in patients with moderate
proteinuria on presentation was 2.5 times greater, and with
heavy proteinuria 6.3 times greater than those with mild pro-
teinuria(P < 0.05). Four patients out of 33 with mild proteinuria
at presentation later developed greater proteinuria, two in the
moderate and two in the heavy range. These increases in
proteinuria occurred within one year after presentation except
for one patient who developed nephrotic levels and a rapid
decline in renal function after three years. Thus, the data
demonstrate not only a poor outcome when proteinuria reaches
levels exceeding 1 g per day at any time during the course of
IgA nephropathy, but also the highly favorable prognosis of
minimal proteinuria at onset. Only rarely did a patient with
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Fig. 2. Latest serum creatinine according to level of proteinuria in IgA
nephropathy. Fifteen patients in whom proteinuria exceeded I g.
reached serum creatiniries in excess of 2 mg/dl, 7 of whom developed
end-stage renal failure. Serum creatinine never exceeded 2 mg/dl in
those with less than I g of proteinuria, even though mean follow up
period was the longest in this group.
indicating the frequent association of hypertension with renal
functional impairment in this disease. In 20 of 22 patients (90%)
moderate to heavy proteinuria antedated hypertension, demon-
strating the rarity of hypertension in patients with mild protein-
uria and underlining extent of proteinuria as an earlier prognos-
tic feature than hypertension.
Renal function
At the time of latest observation, seven patients (9.5%) had
developed end-stage renal failure (Fig. 2). Of these, one pre-
sented with uremia, while the others developed it 1, 3, 5-3/4, 8,
and 13 years after presentation. Eight additional patients pro-
gressed to renal insufficiency (serum creatinines ranging from
2.1 to 8,5 mg/dl). The relative risk of renal insufficiency (serum
creatinine exceeding 2 mg/dl) was 12.88 times greater in patients
who were 30 years and older than that for patients under 30
years (P < 0.001), and 1.85 times greater in males than in
females (NS). The rate of decline in renal function varied
widely. At latest observation, 59 patients had serum creatinines
of 2 mg/dl or less.
Correlations with proteinuria
Mean age at presentation of renal disease was 22 15.9, 33
20.9 and 34 17.4 years in Groups I, II and III, respectively
(NS). There was an increase in male preponderance with
increasing concentrations of proteinuria, with male to female
ratios of 1:4, 1:9 and 2:1 in the groups (NS). Recurrent gross
hematuria occurred most often in Group 1, 55%, compared to
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Fig. 3. "Renal survival" (serum creatinine 2 ing/dI or less) inpatients
with different maximal levels proteinuria during the course of/gA
nephropathy. Sixty-seven patients with serum creatinines not in excess
of 2 mg/dl at presentation are the subjects of this analysis. "Survival"
was significantly foreshortened in Group lit as compared to Group I: P
< 0.001. "Renal survival" 5 years after the first appearance of heavy
proteinuria was 55% (not shown). The numbers of patients under
observation each year are shown along the curves.
minimal proteinuria at presentation convert to a greater level
carrying the increased likelihood of ultimate renal failure.
Proteinuria and morphologic features. The percentage of
patients with different morphologic features according to level
of proteinuria at the time of renal biopsy is shown in Table 1.
Mesangial proliferation was more frequent and more severe
with moderate and heavy proteinuria, as were the incidences of
segmental and global proliferation in glomeruli. Increasing
percentages of patients manifested small crescents and circum-
ferential crescents according to level of proteinuria, but these
correlations did not reach statistical significance. An increase in
disease-related glomerular sclerosis as previously defined by us
18, 19] was found in 24%, 53% and 59% of patients at the
different levels of proteinuria (Chi-squared 2Df = 6.148, P <
0.05; mild vs. heavy P <0.05).
On electron microscopic examination, only podocyte efface-
ment bore a statistical correlation to level of proteinuria. It was
present in 43% of those with mild, 94% of those with moderate
and 92% of those with heavy proteinuria and was more severe
in the latter two groups. No correlation existed between level of
proteinuria and increase in mesangial matrix, nor was there a
correlation between level of proteinuria and deposits in the
mesangium, subendothelial, intramembranous or epimem-
branous regions, glomerular basement membrane abnormali-
ties, or the prevalence of immunoglobulins M or G.
Interstitial infiltration and tubular atrophy were present in
greater numbers of patients and with greater severity at the
higher levels of proteinuria. Vascular sclerosis was of greater
severity in those with greater proteinuria, although its incidence
did not differ significantly among the different groups.
Five patients with persistent heavy proteinuria underwent
biopsy prior to deterioration of renal function, when serum
creatinine concentrations were less than 2 mg/dl. Upon follow
Time, years
Fig. 4. ''Renal survival'' (serwn creatinine 2 mg/dI or less) according
to level of proteinuria at the time of presentation with IgA nephropathy.
Sixty-four patients with serum creatinines not in excess of 2 mg/dI at
presentation are the subjects of this analysis. Relataive risk of renal
functional impairment (serum creatinine over 2 mg/dl): moderate vs.
mild—2.5, heavy vs. mild—6.3. The numbers of patients under obser-
vation each year are shown along the curves.
up, four developed end stage failure and the fifth had a serum
creatinine concentration of 2.1 mgldl. The morphological fea-
tures of these patients consisted of mesangial proliferation,
segmental and global proliferation, partial and circumferential
crescents, "significant" or disease related glomerulosclerosis,
vascular sclerosis and tubulointerstitial changes. The findings in
these patients support the view that heavy proteinuria may be a
marker of advanced morphological damage even prior to clini-
cally evident renal functional impairment.
Discussion
The present study demonstrates the prognostic significance
of level of proteinuria in IgA nephropathy. Mild proteinuria at
presentation predicted a favorable outcome, since fewer than
one in eight later developed heavier proteinuria, and none who
remained with minimal proteinuria (Group I) progressed to
renal insufficiency. Forty percent of those who reached heavy
levels of proteinuria (Group HI) and 25% in whom the maxi-
mum excretion was moderate (Group II) developed increased
serum creatinine concentrations, while this never occurred in
any patient with mild proteinuria. One-sixth of those with more
than minimal proteinuria progressed to end-stage renal failure.
Compared to patients with mild proteinuria at onset, the rela-
tive risk of ultimately incurring renal functional impairment was
2.5 times greater in the group who started with moderate
proteinuria and 6.3 times greater in those who had heavy
proteinuria on presentation. Hypertension was observed as a
concomitant of renal functional impairment in a significant
number of patients but more importantly, the present data
demonstrate that heavy proteinuria precedes the appearance of
hypertension in the majority of cases. These findings in IgA
nephropathy serve to underscore the significance of impaired
permselectivity as an early and sensitive marker of glomerular
injury.
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Table 1. Level of proteinuria and morphological features
Morphological features in IGA nephropathy classified according to level of proteinuria at the time of renal biopsy
Kruskal-Wallis test for ordered classification
Chi-Squared for 2Df
Other investigators have shown that heavier proteinuria
carries a poor prognosis in this disease, based on outcome at the
end of a follow up period without the use of life table analysis
[6, 7, 10, 11, 13, 20, 21]. When life table analysis has been
utilized, patients with fairly advanced renal insufficiency may
have been included at the entry point [22]. Identification of
heavier proteinuria as an early prognostic feature is not
achieved in these studies. In this regard our study is comparable
to those of Droz et al from France [231 and Chida, Tomura and
Takeuchi from Japan [24], and emphasizes the predictive value
of protein excretion rate early in IgA nephropathy.
When heavy proteinuria appeared during the course of IgA
nephropathy, it proved to be persistent and carried with it a
poor prognosis, as summarized above. However, in a small
subset of patients who had an onset with heavy proteinuria
associated with features similar to "acute nephritis," that is,
with fluid retention and transient hypertension, a remission in
proteinuria often occurred and they suffered no subsequent
renal functional impairment. This form of presentation has also
been reported by D'Amico et al [9] and by Clarkson et a! [201.
Heavy proteinuria was common in the present study, occur-
ring in one-third of patients. A similar prevalence has been
observed by Croker, Dawson and Sanfihipo [12], although
others have generally reported a less frequent occurrence,
ranging from 4% to 18% [7, 9, 10, 13, 19]. This cannot be
explained by any significant difference in selection of patients
for biopsy, since the various modes of presentation were
represented equally in these other series and in ours.
The appearance of heavy proteinuria many months or years
after onset and its relative infrequency set IgA nephropathy
apart from most other primary glomerular diseases in which the
nephrotic syndrome occurs. Minimal change, membranous
nephropathy and focal glomerular sclerosis display heavy pro-
teinuria almost invariably and typically on presentation. The
delayed appearance of nephrotic syndrome in IgA nephropathy
resembles somewhat the course of membranoproliferative gb-
merulonephritis, in which heavy proteinuria, albeit more com-
mon, is often not manifested until years of disease have
elapsed, and has a similarly poor prognosis. In a multivariate
analysis of age, recurrent macroscopic hematuria, proteinuria
and hypertension, D'Amico et al have shown proteinuria of
greater than I g/day to be the only independent clinical feature
associated with poor prognosis [22].
Not unexpectedly, an association between level of protein-
uria and severity of morphological damage was observed,
supporting the unfavorable prognostic import of greater protein
loss. Both proliferative and scierosing lesions correlated with
level of proteinuria, as did tubulointerstitial damage and vascu-
lar sclerosis, and disease-related glomerulosclerosis was pre-
sent in more patients with heavier proteinuria. A correlation
between glomerulosclerosis and heavy proteinuria has been
noted similarly by others [13, 19]. In examining the morpholog-
Proteinuria
Mild
<1 g
27
I
Moderate
= 2.9 g
Heavy
>3 g P value
No. of patients 21 20
Mesangial proliferation
Absent 26% 0% 0% Mild vs. mod. <0.05
Grade 1 11% 14% 5% Mild vs. heavy <0.01
Grade 2 63% 86% 95% Overall <0.Ola
Segmental proliferation 18.5% 42.9% 55% Mild vs. heavy <0.05
Global proliferation 0% 4.8% 25% Overall <O.O3
Partial crescents 11% 28.6% 35% Overall <003b
Circumferential crescents 0% 4.8% 10% NS
Disease-related or "significant" 24% 52.6% 58.8% NS <0.05
glomerulosclerosis Overall <O.O5'
Podoc yte effacement
Absent 56.5% 6.25% 7.7% Mild vs. heavy <0.001
Grade I 43.5% 81.25% 76.9% Mild vs. mod. <0.001
Grade 2 0% 12.5% 15.4% Mild vs. heavy
Mod. vs. heavy
Overall
NS
<0.005"
Interstitial infiltraiton
Absent 66.6% 42.9% 25% Mild vs. mod. <0.05
Grade I 33.3% 38.1% 50% Mild vs. heavy <0.05
Grade 2 0% 19% 25% Overall <0.02"
Tubular atrophy
Absent 70.4% 33.3% 20% Mild vs. mod. <0.003
Grade I 29.6% 38.1% 45% Mild vs. heavy <0.001
Grade 2 0% 28.6% 35% Overall <0.005"
Vascular sclerosis
Absent 63% 33.3% 50% Mild vs. mod. <0.01
Grade I 11% 14.3% 0% Mild vs. heavy <0.05
Grade 2 26% 19% 5% Overall <0.03
Grade 3 0% 33.3% 45%
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ical features of a subset of patients with normal renal function
and heavy proteinuria who eventually developed functional
loss, we noted severe structural damage. The findings in these
patients demonstrate that heavy proteinuria is a highly sensitive
marker of glomerular damage in IgA nephropathy.
Our study also indicates that older age at presentation carries
a poor prognosis. However, in IgA nephropathy, which may be
recognized only by casual discovery of abnormal urinalysis or
by manifestations of advanced disease, precise time of onset is
often unknown. Hence it is not possible to state with certainty
whether the disease is necessarily more severe as it occurs in
older patients or whether these individuals represent a selected
group in whom ongoing disease has been present for a longer
period prior to diagnosis.
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